US4164558A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for optimizing reagents for agglutination reactions
Assignee: Massachusetts Institute of Technology
•
Filing: 1976-11-22
•
Granted: 1979-08-14
•
Expires: 1996-11-22
Abstract
Abstract A method and compositions are provided to effect optimization of methods for determining concentrations of antibodies or antigens. Particles coated with an antigen or an antibody are suspended in an aqueous medium where pH and ionic strength are controlled so that the coulomb effect and the van der Waals forces on and exerted by the particles are balanced.
Inventors
- 👤 Gustav K. von Schulthess
- 👤 Richard J. Cohen
- 👤 George B. Benedek
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 03:13
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54393; Y; Y10; Y10S; Y10S435/00; Y10S435/962
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
144 words
The process for forming a composition comprising an aqueous suspension of antigen-coated or antibody-coated particles to maximize sensitivity for determining the concentration of the agglutinator for the composition which comprises (A) coating carrier particles with the antigen or antibody, (B) suspending the coated particles in a liquid having a pH as far as possible from the isoelectric point of the particle coating without significantly reducing the binding capacity of the coating, to maximize particle charge, (C) increasing the ionic strength of the composition obtained by (B) to reduce the range of coulomb interaction until nonspecific agglutination occurs and (D) reducing the ionic strength of the composition by (C) to just below that where nonspecific agglutination occurs so that coulomb effect and the van der Waals forces on and exerted by the particles are balanced to effect determination of a minimum concentration of the agglutinator.
Claim 2
Dependent Claim
144 words
The process for forming a composition comprising an aqueous suspension of antigen-coated or antibody-coated particles to maximize sensitivity for determining the concentration of the agglutinator for the composition which comprises (A) coating carrier particles with the antigen or antibody, (B) suspending the coated particles in a liquid having a pH as far as possible from the isoelectric point of the particle coating without significantly reducing the binding capacity of the coating, to maximize particle charge, (C) increasing the ionic strength of the composition obtained by (B) to reduce the range of coulomb interaction until nonspecific agglutination occurs and (D) reducing the ionic strength of the composition by (C) to just below that where nonspecific agglutination occurs so that coulomb effect and the van der Waals forces on and exerted by the particles are balanced to effect determination of a minimum concentration of the agglutinator.
Claim 3
Dependent Claim
22 words
The process of claim 1 wherein the average size of the particles is between about 0.05 μm M and 5 μm M.
Claim 4
Dependent Claim
19 words
The process of claim 1 wherein the concentration of said particles is between about 1 μg/ml and 500 μg/ml.
Claim 5
Dependent Claim
11 words
The process of claim 1 wherein the particles are polystyrene particles.
Claim 6
Dependent Claim
11 words
The process of claim 2 wherein the particles are polystyrene particles.
Claim 7
Dependent Claim
11 words
The process of claim 3 wherein the particles are polystyrene particles.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-08-13 | 1983-02-12 | 1983-08-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-08-13 | 1987-02-12 | 1987-08-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-08-13 | 1991-02-12 | 1991-08-14 | $7700.00 | Window Closed / Lapsed |